MedStar Georgetown University Hospital is one of the national capital area's oldest academic teaching hospitals.

There are 609 beds in Georgetown University Hospital.

During the past decade, Georgetown University Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Georgetown University Hospital" are "Symptomatic Neurogenic Orthostatic Hypotension" (2 trials), "MSA" (1 trials), "Parkinson's Disease (PD)" (1 trials) and "Pure Autonomic Failure (PAF)" (1 trials). Many other conditions were trialed in "Georgetown University Hospital" in a lesser frequency.

Most popular intervention types in "Georgetown University Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials) and "ampreloxetine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Georgetown University Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Georgetown University Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Georgetown University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Georgetown University Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".